Apr 11, 2024, 13:50
New blood test predicts clinical benefit to IO AND identifies which patient will develop toxicity by Jarushka Naidoo – LUNGevity Foundation
LUNGevity Foundation shared on X/Twitter:
“50% patients develop side effects from immunotx. New blood test predicts clinical benefit to IO AND identifies which patient will develop toxicity and require proactive monitoring. Important question esp for PD-L1>50% Great presentation by Jarushka Naidoo. AACR24″
Source: LUNGevity Foundation/X